Search research articles
Contact Us
Filters
Showing results (1-10 of 369) with videos related to
Page
of 37
Sort By:
The Oncologist
|
December 24, 2004
Topotecan in the treatment of recurrent small cell lung cancer: an update
Andrea Ardizzoni
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]
|
April 8, 2004
[State of the art in the treatment of stage IIIA non-small cell lung tumors]
Andrea Ardizzoni, Vittorio Franciosi
JAMA
|
April 8, 2004
Predictors of clinical response of non-small cell cancer to gefitinib
Andrea Ardizzoni, Marcello Tiseo
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]
|
November 6, 2002
Histone deacetylation inhibitors
Andrea Ardizzoni, Maura Loprevite
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 1, 2007
Current status of second-line treatment and novel therapies for small cell lung cancer
Marcello Tiseo, Andrea Ardizzoni
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 26, 2007
Combination of target agents: challenges and opportunities
Andrea Ardizzoni, Marcello Tiseo
Anti-Cancer Drugs
|
September 13, 2013
Colorectal cancer patient on maintenance dialysis successfully treated with cetuximab
Elisa Fontana, Francesca Pucci, Andrea Ardizzoni
Cancer Immunology, Immunotherapy : CII
|
April 7, 2018
Immune-mediated cholangitis: is it always nivolumab's fault?
Francesco Gelsomino, Giovanni Vitale, Andrea Ardizzoni
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2014
Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: a pooled analysis of topotecan second-line trials
Andrea Ardizzoni, Marcello Tiseo, Luca Boni
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?
Marcello Tiseo, Luca Boni, Andrea Ardizzoni
Page
of 37
Search research articles
Search
Showing results (1-10 of 369) with videos related to
Sort By:
Page
of 37
The Oncologist
|
December 24, 2004
Topotecan in the treatment of recurrent small cell lung cancer: an update
Andrea Ardizzoni
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]
|
April 8, 2004
[State of the art in the treatment of stage IIIA non-small cell lung tumors]
Andrea Ardizzoni, Vittorio Franciosi
JAMA
|
April 8, 2004
Predictors of clinical response of non-small cell cancer to gefitinib
Andrea Ardizzoni, Marcello Tiseo
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]
|
November 6, 2002
Histone deacetylation inhibitors
Andrea Ardizzoni, Maura Loprevite
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 1, 2007
Current status of second-line treatment and novel therapies for small cell lung cancer
Marcello Tiseo, Andrea Ardizzoni
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 26, 2007
Combination of target agents: challenges and opportunities
Andrea Ardizzoni, Marcello Tiseo
Anti-Cancer Drugs
|
September 13, 2013
Colorectal cancer patient on maintenance dialysis successfully treated with cetuximab
Elisa Fontana, Francesca Pucci, Andrea Ardizzoni
Cancer Immunology, Immunotherapy : CII
|
April 7, 2018
Immune-mediated cholangitis: is it always nivolumab's fault?
Francesco Gelsomino, Giovanni Vitale, Andrea Ardizzoni
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2014
Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: a pooled analysis of topotecan second-line trials
Andrea Ardizzoni, Marcello Tiseo, Luca Boni
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?
Marcello Tiseo, Luca Boni, Andrea Ardizzoni
Page
of 37